Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rinck, P.
Right arrow Articles by Borseth, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rinck, P.
Right arrow Articles by Borseth, A

Radiology, Vol 178, 775-779, Copyright © 1991 by Radiological Society of North America

ARTICLES

Oral magnetic particles in MR imaging of the abdomen and pelvis

PA Rinck, O Smevik, G Nilsen, O Klepp, M Onsrud, A Oksendal and A Borseth
MR Center, University of Trondheim, Norway.

Two phase 2 clinical trials of an oral superparamagnetic contrast agent for enhancement on magnetic resonance images of the intestine were performed. In trial 1, 31 male patients with cancer of the testis underwent follow-up examinations of the abdomen at 0.5 and 1.5 T after oral administration of magnetic particles. In trial 2, 31 female patients with pelvic and lower abdominal disease were examined at 1.5 T after administration of the contrast material. The patients each ingested 800 mL of contrast material over approximately 2 hours. Concentrations of 0.25 and 0.5 g/L did not induce blurring or metallic artifacts. Distribution was homogeneous through the gastrointestinal tract. In all patients, a loss of signal intensity was observed on proton density-, T1-, and T2-weighted images. The diagnostic information from postcontrast images in trial 2 was greater in 16 patients (52%). Contrast enhancement was independent of field strength; no major side effects were observed. Artifacts from moving bowels were less troublesome, and delineation of intraabdominal and pelvic organs was better with the use of oral magnetic particles.


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
M. H. Fuchsjager, A. G. Maier, W. Schima, E. Zebedin, F. Herbst, M. Mittlbock, F. Wrba, and G. L. Lechner
Comparison of Transrectal Sonography and Double-Contrast MR Imaging When Staging Rectal Cancer
Am. J. Roentgenol., August 1, 2003; 181(2): 421 - 427.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1991 by the Radiological Society of North America.